108 related articles for article (PubMed ID: 8204353)
21. 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research.
Levard H; Pouliquen X; Hay JM; Fingerhut A; Langlois-Zantain O; Huguier M; Lozach P; Testart J
Eur J Surg; 1998 Nov; 164(11):849-57. PubMed ID: 9845131
[TBL] [Abstract][Full Text] [Related]
22. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.
Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305
[TBL] [Abstract][Full Text] [Related]
23. Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study.
Tryakin A; Pokataev I; Kononets P; Fedyanin M; Bokhyan V; Malikhova O; Minin K; Shogenov M; Stilidi I; Vybarava A; Davydov M; Tjulandin S
Jpn J Clin Oncol; 2016 Jul; 46(7):610-4. PubMed ID: 27052115
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Cervantes A; Villar-Grimalt A; Abad A; Antón-Torres A; Belón J; Dorta J; Tres A; Camps C; Fonseca E; Massutí B
Ann Oncol; 1993 Nov; 4(9):753-7. PubMed ID: 8280656
[TBL] [Abstract][Full Text] [Related]
25. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
[TBL] [Abstract][Full Text] [Related]
26. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial.
Stahl M; Wilke H; Fink U; Stuschke M; Walz MK; Siewert JR; Molls M; Fett W; Makoski HB; Breuer N; Schmidt U; Niebel W; Sack H; Eigler FW; Seeber S
J Clin Oncol; 1996 Mar; 14(3):829-37. PubMed ID: 8622031
[TBL] [Abstract][Full Text] [Related]
27. Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival.
Bamias A; Hill ME; Cunningham D; Norman AR; Ahmed FY; Webb A; Watson M; Hill AS; Nicolson MC; O'Brien ME; Evans TC; Nicolson V
Cancer; 1996 May; 77(10):1978-85. PubMed ID: 8640659
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
29. A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenocarcinoma.
Spiridonidis CH; Laufman LR; Jones JJ; Gray DJ; Cho CC; Young DC
Cancer; 1996 Nov; 78(10):2070-7. PubMed ID: 8918399
[TBL] [Abstract][Full Text] [Related]
30. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up.
Ancona E; Ruol A; Castoro C; Chiarion-Sileni V; Merigliano S; Santi S; Bonavina L; Peracchia A
Ann Surg; 1997 Dec; 226(6):714-23; discussion 723-4. PubMed ID: 9409570
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus.
Belani CP; Luketich JD; Landreaneau RJ; Kim R; Ramanathan RK; Day R; Ferson PF; Keenan RJ; Posner M; Seeger J; Lembersky B
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-89-S19-92. PubMed ID: 9427275
[TBL] [Abstract][Full Text] [Related]
33. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
34. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus.
Stuschke M; Stahl M; Wilke H; Walz MK; Oldenburg AR; Stüben G; Jahnke K; Seeber S; Sack H
Oncology; 1999; 57(2):99-105. PubMed ID: 10461055
[TBL] [Abstract][Full Text] [Related]
35. [The role of neoadjuvant therapy in the treatment of locally advanced squamous cell cancer of the cervical oesophagus].
Papp A; Cseke L; Varga G; Pavlovics G; Potó L; Márton S; Farkas R; Bellyei S; Horváth OP
Magy Seb; 2012 Oct; 65(5):340-7. PubMed ID: 23086818
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
37. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
[TBL] [Abstract][Full Text] [Related]
38. [Usefulness of combination therapy with expandable metallic stent replacement and FLEP chemotherapy (consisting of 5-FU, leucovorin, etoposide and cisplatin) for advanced esophageal cancer invading the bronchus: a case report].
Kohno S; Hada T; Oda Y; Kobayashi I; Ohmori H; Sasaya K; Matai K; Yamazaki Y
Gan To Kagaku Ryoho; 1999 Aug; 26(9):1349-53. PubMed ID: 10478191
[TBL] [Abstract][Full Text] [Related]
39. Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma.
Alici S; Buyukberber S; Alkis N; Benekli M; Ozkan M; Bilici A; Demirci U; Karaca H; Arpaci E; Gumus M; Altunbas M; Dane F; Turk HM;
Asian Pac J Cancer Prev; 2013; 14(1):423-7. PubMed ID: 23534766
[TBL] [Abstract][Full Text] [Related]
40. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
